Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases
Disease Category: Asthma (Pediatric)
Trial Information
Phase 1 Pharmacokinetics of Intravenous Nexium in Children
The purpose of this research study is to evaluate how much of repeated once daily intravenous (IV, meaning through a vein) doses of esomeprazole gets into the bloodstream of hospitalized children aged 0-17 years old that require acid suppression therapy.
Patient Inclusion Criteria:
- parent/guardian must sign consent form and the child will be asked to sign and Assent Form if he/she is old enough and is able to sign
- verbal assent will be acceptable if the child is old enough to understand, but unable to write
- female and/or male hospitalized patients aged 0-17 years old who should be considered for treatment with acid suppressive therapy.
Patient Exclusion Criteria:
- female patients that are pregnant, or plan to become pregnant during the study period or is breast-feeding a child
- patients with a history of multiple drug allergies
- any illness, medical history, abnormal laboratory values, abnormal physical examination findings or abnormal vitals signs that could put the patient at risk when participating in the study
Kelly Colucci, Manager, Grants and Contracts
Atlantic Health System
475 South Street
Morristown, NJ 07962
Phone: 973-660-3139
EMail: kelly.colucci@atlantichealth.org
View Google Map
Research Center Information: Atlantic Health System
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
